Pasithea Therapeutics Corp. (KTTA)
0.49
0.00 (0.00%)
USD |
NASDAQ |
Oct 22, 09:51
Pasithea Therapeutics Market Cap : 16.37M for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 21, 2026 | 16.30M |
| October 20, 2026 | 13.70M |
| October 19, 2026 | 13.78M |
| October 16, 2026 | 14.03M |
| October 15, 2026 | 13.70M |
| October 14, 2026 | 13.68M |
| October 13, 2026 | 14.16M |
| October 12, 2026 | 14.95M |
| October 09, 2026 | 15.62M |
| October 08, 2026 | 14.73M |
| October 07, 2026 | 14.82M |
| October 06, 2026 | 14.94M |
| October 05, 2026 | 15.20M |
| October 02, 2026 | 15.91M |
| October 01, 2026 | 16.34M |
| September 30, 2026 | 16.47M |
| September 29, 2026 | 16.37M |
| September 28, 2026 | 16.04M |
| September 25, 2026 | 16.68M |
| September 24, 2026 | 17.16M |
| September 23, 2026 | 17.13M |
| September 22, 2026 | 17.18M |
| September 21, 2026 | 17.05M |
| September 18, 2026 | 17.50M |
| September 17, 2026 | 16.93M |
| Date | Value |
|---|---|
| September 16, 2026 | 16.37M |
| September 15, 2026 | 16.71M |
| September 14, 2026 | 17.04M |
| September 11, 2026 | 17.71M |
| September 10, 2026 | 18.04M |
| September 09, 2026 | 19.04M |
| September 08, 2026 | 20.02M |
| September 04, 2026 | 19.38M |
| September 03, 2026 | 19.39M |
| September 02, 2026 | 19.39M |
| September 01, 2026 | 18.81M |
| August 31, 2026 | 19.18M |
| August 28, 2026 | 18.71M |
| August 27, 2026 | 18.53M |
| August 26, 2026 | 19.05M |
| August 25, 2026 | 18.71M |
| August 24, 2026 | 16.87M |
| August 21, 2026 | 18.02M |
| August 20, 2026 | 15.70M |
| August 19, 2026 | 16.37M |
| August 18, 2026 | 16.63M |
| August 17, 2026 | 15.97M |
| August 14, 2026 | 16.06M |
| August 13, 2026 | 15.97M |
| August 12, 2026 | 16.37M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.513B |
| Alnylam Pharmaceuticals, Inc. | 30.41B |
| Anika Therapeutics, Inc. | 272.48M |
| Savara, Inc. | 965.38M |
| Vericel Corp. | 2.099B |
Market Cap Related Metrics
| Price to Book Value | 0.3285 |
| Price | 0.49 |
| Earnings Yield | -322.4% |